H. . Brandi, S. Schneider, and L. . Ryttig, “Incremental Risk of Adverse Events with Oral Janus Kinase Inhibitor Use in Atopic Dermatitis and Other Indications: A Systematic Review and Meta-Analysis”, J of Skin, vol. 8, no. 1, p. s320, Jan. 2024.